Ionis Pharmaceuticals | IONS - Gross Profit On Sales


Ionis Pharmaceuticals reported $195M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Agios Pharmaceuticals USD 18.09M 6.89M Dec/2025
Alnylam Pharmaceuticals USD 829.31M 219.56M Dec/2025
Arrowhead Research USD 256.47M 228.7M Sep/2025
Astellas Pharma JPY 456.81B 38.02B Dec/2025
BioCryst Pharmaceuticals USD 153.05M 4.16M Dec/2025
BioMarin Pharmaceutical USD 713.01M 81.81M Dec/2025
Celltrion KRW 626.11B 81.75B Sep/2025
Cspc Pharmaceutical CNY 4.01B 329.18M Dec/2025
Deva Holding AS TRY 1.32B 235.77M Sep/2023
Divis Laboratories Ltd INR 16.59B 2.05B Dec/2025
Esperion Therapeutics USD 140.59M 94.57M Dec/2025
Exelixis USD 572.18M 7M Dec/2025
Halozyme Therapeutics USD 281.77M 2.41M Sep/2025
Ionis Pharmaceuticals USD 195M 40M Dec/2025
Kangmei Pharma CNY 270.29M 20.26M Sep/2025
Knight Therapeutics CAD 64.72M 8.91M Dec/2025
Laboratorios Farma EUR 105.28M 177.08M Jun/2025
Medical Developments International AUD 7.35M 7.37M Jun/2025
Moderna USD 226M 583M Dec/2025
Nektar Therapeutics USD 21.81M 8.06M Dec/2025
Neuren Pharmaceuticals AUD 6.69M 6.37M Jun/2025
Neurocrine Biosciences USD 787.9M 7M Dec/2025
Novartis USD 10.25B 570M Dec/2025
Omeros USD -33.16M 18.52M Jun/2024
OPKO Health USD 45M 1.89M Dec/2025
Organigram Holdings CAD 23.32M 8.52M Dec/2025
Pfizer USD 3.54B 7.61B Sep/2025
Pharma Mar EUR 86.7M 53.34M Dec/2025
PTC Therapeutics USD 148.38M 39.31M Dec/2025
Qiagen NV USD 325.27M 19.53M Dec/2025
Regeneron Pharmaceuticals USD 3.3B 67M Dec/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Sarepta Therapeutics USD 43.55M 204.36M Dec/2025
Sartorius EUR 393.2M 23M Sep/2025
Sino Biopharmaceutical CNY 10.5B 2.53B Dec/2024
Tilray USD 57.47M 10.16M Jun/2025
Ultragenyx Pharmaceutical USD 178M 46.06M Dec/2025
Vertex Pharmaceuticals USD 2.72B 62.4M Dec/2025
Zealand Pharma A/S 68.91M 19.35M Dec/2025
Zz Pientze Pharmaceu CNY 296.13M 1.1B Jun/2025